The Lawyer’s new China Elite report contains the most detailed research available on the PRC legal market and contains unparalleled insight into the country's leading law firms. They vary in size, practice focus and geographic coverage, but they all share one common quality – ambition... Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
Allen & Overy (A&O) and Travers Smith have continued to reap the benefit of the upturn in private equity buyouts after acting on the sale of swine flu soap manufacturer Deb Group.
Travers Smith, led by corporate partner Paul Dolman, acted for the seller, Barclays Private Equity (BPE), on a deal valued at £325m. Tax partner Kathleen Russ also acted on the transaction. Derek Baird led the A&O team acting for buyer Charterhouse Capital Partners on the transaction.
Travers Smith won the BPE mandate after advising the Deb management on its initial sale in 2004, when the private equity house invested £135m to take a 55 per cent stake in the business. The latest deal was slated to go ahead in the summer of 2008 before being put on the back burner following the collapse of Lehman Brothers. The hiatus proved profitable for the skincare products manufacturer, with last year’s swine flu scare prompting an increase in sales of industrial hand cleaner Swarfega.
The year to December 2009 saw Deb generate sales in excess of £122m. The company came to market in September 2009. UBS ran the auction with several other private equity houses understood to be among the bidders with Charterhouse.
Dolman said: “It’s especially pleasing in that 18 months ago we would have struggled to get this away.”
Travers Smith has already won mandates on several other of this year’s private equity deals, including the Pets At Home buyout by Kohlberg Kravis Roberts & Co and ICG’s investment in CPA Global.